Рет қаралды 127
Commissioner of the United States Food and Drug Administration Robert M. Califf discusses the application of AI at the FDA. ARPA-H’s Director of the Proactive Health Office Wade Shen discusses an AI Aspiration for new medicines for seemingly intractable diseases in months rather than decades.